BioAmber (BIOA) Misses Q2 EPS by 4c

BioAmber (NYSE: BIOA) reported Q2 EPS of ($0.26), $0.04 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $3.7 million versus the consensus estimate of $3.85 million.

For earnings history and earnings-related data on BioAmber (BIOA) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• C3.ai (AI) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY27 Revenue Guidance
• Netskope, Inc. (NTSK) Tops Q1 EPS by 1c, Offers Guidance